ALZHEIMER'S DISEASE SEQUENCING PROJECT PHENOTYPE HARMONIZATION CONSORTIUM - ABSTRACT IN RESPONSE TO PAR-20-099 “HARMONIZATION OF ALZHEIMER’S DISEASE AND RELATED DEMENTIAS (AD/RD) GENETIC, EPIDEMIOLOGIC, AND CLINICAL DATA TO ENHANCE THERAPEUTIC TARGET DISCOVERY”, WE HAVE ASSEMBLED A MULTIDISCIPLINARY TEAM THAT INCLUDES EXPERTS IN NEUROIMAGING, NEUROPSYCHOLOGY, FLUID BIOMARKERS, NEUROPATHOLOGY, AND VASCULAR CONTRIBUTIONS TO ADRD TO WORK IN CLOSE PARTNERSHIP WITH THE NIH AND THE ALZHEIMER’S DISEASE SEQUENCING PROJECT (ADSP). OUR ADSP PHENOTYPE HARMONIZATION CONSORTIUM, OR “ADSP-PHC”, SEEKS TO WORK IN COORDINATION WITH EXISTING ADSP WORKGROUPS AND INITIATIVES TO (1) STREAMLINE ACCESS TO ENDOPHENOTYPE DATA, (2) PROVIDE HIGH QUALITY ENDOPHENOTYPE HARMONIZATION ACROSS MULTIPLE RESEARCH DOMAINS, AND (3) PROVIDE COMPREHENSIVE DOCUMENTATION OF BOTH DATA AVAILABILITY AND HARMONIZATION PROCEDURES. THIS PROJECT INCLUDES TWO COORDINATING CENTERS, THREE CORES, AND EIGHT DOMAIN- SPECIFIC HARMONIZATION TEAMS LED BY WORLD-RENOWNED EXPERTS IN THEIR FIELDS. WHILE OUR EFFORTS WILL FOCUS ON DATA ACCESS, DOCUMENTATION, AND HARMONIZATION, WE WILL WORK CLOSELY WITH OTHER ADSP WORKGROUPS AND OTHER LARGE-SCALE HARMONIZATION EFFORTS TO MAXIMIZE THE IMPACT AND ALIGN WITH NIH PRIORITIES. IN PARTICULAR, WE WILL FOCUS HARMONIZATION ON ADRD-RELATED ENDOPHENOTYPES, INCLUDING COGNITIVE SCORES DERIVED FROM DETAILED NEUROPSYCHOLOGICAL ASSESSMENTS, MEASURES OF NEUROPATHOLOGY MEASURED BOTH EX VIVO (NEUROPATHOLOGICAL ASSESSMENT AT AUTOPSY) AND IN VIVO (FLUID BIOMARKERS AND POSITRON EMISSION TOMOGRAPHY BIOMARKERS), CONCOMITANT PATHWAYS OF INJURY (VASCULAR RISK FACTORS AND VASCULAR BRAIN INJURY), AND MEASURES OF NEURODEGENERATION FOCUSING ON BOTH WHITE (DIFFUSION-WEIGHTED MRI) AND GREY MATTER (T1-WEIGHTED MRI). THE PROPOSED HARMONIZATION EFFORT WILL PROVIDE AN UNPRECEDENTED OPPORTUNITY TO DISENTANGLE THE GENETIC ARCHITECTURE OF INDIVIDUAL BIOLOGICAL CONTRIBUTORS TO ADRD RISK AND PROGRESSION. THE HARMONIZED DATA, PROTOCOLS, AND EDUCATIONAL TOOLS DEVELOPED BY THE ADSP-PHC WILL TRANSFORM THE ADRD LANDSCAPE, ACCELERATE DISCOVERY, AND FACILITATE THE APPLICATION OF EMERGING BIG DATA ANALYTIC APPROACHES LEVERAGING MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE.
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subrecipients: where the money went next
72 subawards totaling $30.47M (125.9% of what was obligated), as Vanderbilt University Medical Center reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.
10 actions since 2023-06-29. Each is a modification or amendment with the money it added or took back.
Date
Amendment
Kind
Amount
What the agency wrote
2026-08-11
001
Revision
$0
ALZHEIMER'S DISEASE SEQUENCING PROJECT PHENOTYPE HARMONIZATION CONSORTIUM - ABSTRACT IN RESPONSE TO PAR-20-099 “HARMONIZATION OF ALZHEIMER’S DISEASE AND RELATED DEMENTIAS (AD/RD) GENETIC, EPIDEMIOLOGIC, AND CLINICAL DATA TO ENHANCE THERAPEUTIC TARGET…
2026-07-29
000
Revision
$0
ALZHEIMER'S DISEASE SEQUENCING PROJECT PHENOTYPE HARMONIZATION CONSORTIUM - ABSTRACT IN RESPONSE TO PAR-20-099 “HARMONIZATION OF ALZHEIMER’S DISEASE AND RELATED DEMENTIAS (AD/RD) GENETIC, EPIDEMIOLOGIC, AND CLINICAL DATA TO ENHANCE THERAPEUTIC TARGET…
2025-08-29
001
Continuation
$8.37M
ALZHEIMER'S DISEASE SEQUENCING PROJECT PHENOTYPE HARMONIZATION CONSORTIUM - ABSTRACT IN RESPONSE TO PAR-20-099 “HARMONIZATION OF ALZHEIMER’S DISEASE AND RELATED DEMENTIAS (AD/RD) GENETIC, EPIDEMIOLOGIC, AND CLINICAL DATA TO ENHANCE THERAPEUTIC TARGET…
2025-06-12
000
Revision
$0
ALZHEIMER'S DISEASE SEQUENCING PROJECT PHENOTYPE HARMONIZATION CONSORTIUM - ABSTRACT IN RESPONSE TO PAR-20-099 “HARMONIZATION OF ALZHEIMER’S DISEASE AND RELATED DEMENTIAS (AD/RD) GENETIC, EPIDEMIOLOGIC, AND CLINICAL DATA TO ENHANCE THERAPEUTIC TARGET…
2024-09-17
003
Revision
$0
ALZHEIMER'S DISEASE SEQUENCING PROJECT PHENOTYPE HARMONIZATION CONSORTIUM - ABSTRACT IN RESPONSE TO PAR-20-099 “HARMONIZATION OF ALZHEIMER’S DISEASE AND RELATED DEMENTIAS (AD/RD) GENETIC, EPIDEMIOLOGIC, AND CLINICAL DATA TO ENHANCE THERAPEUTIC TARGET…
2024-08-23
002
Continuation
$8.52M
ALZHEIMER'S DISEASE SEQUENCING PROJECT PHENOTYPE HARMONIZATION CONSORTIUM - ABSTRACT IN RESPONSE TO PAR-20-099 “HARMONIZATION OF ALZHEIMER’S DISEASE AND RELATED DEMENTIAS (AD/RD) GENETIC, EPIDEMIOLOGIC, AND CLINICAL DATA TO ENHANCE THERAPEUTIC TARGET…
2024-05-27
001
Revision
$0
ALZHEIMER'S DISEASE SEQUENCING PROJECT PHENOTYPE HARMONIZATION CONSORTIUM - ABSTRACT IN RESPONSE TO PAR-20-099 “HARMONIZATION OF ALZHEIMER’S DISEASE AND RELATED DEMENTIAS (AD/RD) GENETIC, EPIDEMIOLOGIC, AND CLINICAL DATA TO ENHANCE THERAPEUTIC TARGET…
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-09-30). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗
University of Texas Health Science Center of San Antonio
$1.27M
THE GOAL OF THIS COORDINATED NATIONAL INITIATIVE ? THE AD SEQUENCING PROJECT PHENOTYPE HARMONIZATION CONSORTIUM, OR ?ADSP-PHC? - IS TO PROVIDE A CENTRALIZED DATABASE OF ROBUST ENDOPHENOTYPES FOR LARGE-SCALE GENOMIC…
2022-11-01
University of Miami
$1.15M
THE GOAL OF THIS COORDINATED NATIONAL INITIATIVE ? THE AD SEQUENCING PROJECT PHENOTYPE HARMONIZATION CONSORTIUM, OR ?ADSP-PHC? - IS TO PROVIDE A CENTRALIZED DATABASE OF ROBUST ENDOPHENOTYPES FOR LARGE-SCALE GENOMIC…
2024-10-07
Boston Va Research Institute, Inc.
$1.13M
MVP DATA INTEGRATION INTO THE ADSP PHENOTYPE HARMONIZATION CONSORTIUM
2025-09-23
Boston Va Research Institute, Inc.
$1.09M
MVP DATA INTEGRATION INTO THE ADSP PHENOTYPE HARMONIZATION CONSORTIUM
THE GOAL OF THIS COORDINATED NATIONAL INITIATIVE ? THE AD SEQUENCING PROJECT PHENOTYPE HARMONIZATION CONSORTIUM, OR ?ADSP-PHC? - IS TO PROVIDE A CENTRALIZED DATABASE OF ROBUST ENDOPHENOTYPES FOR LARGE-SCALE GENOMIC…
THE GOAL OF THIS COORDINATED NATIONAL INITIATIVE ? THE AD SEQUENCING PROJECT PHENOTYPE HARMONIZATION CONSORTIUM, OR ?ADSP-PHC? - IS TO PROVIDE A CENTRALIZED DATABASE OF ROBUST ENDOPHENOTYPES FOR LARGE-SCALE GENOMIC…
2024-05-13
000
Revision
$1.14M
ALZHEIMER'S DISEASE SEQUENCING PROJECT PHENOTYPE HARMONIZATION CONSORTIUM - ABSTRACT IN RESPONSE TO PAR-20-099 “HARMONIZATION OF ALZHEIMER’S DISEASE AND RELATED DEMENTIAS (AD/RD) GENETIC, EPIDEMIOLOGIC, AND CLINICAL DATA TO ENHANCE THERAPEUTIC TARGET…
2023-08-15
001
Continuation
$6.18M
ALZHEIMER'S DISEASE SEQUENCING PROJECT PHENOTYPE HARMONIZATION CONSORTIUM - ABSTRACT IN RESPONSE TO PAR-20-099 “HARMONIZATION OF ALZHEIMER’S DISEASE AND RELATED DEMENTIAS (AD/RD) GENETIC, EPIDEMIOLOGIC, AND CLINICAL DATA TO ENHANCE THERAPEUTIC TARGET…
2023-06-29
000
Revision
$0
ALZHEIMER'S DISEASE SEQUENCING PROJECT PHENOTYPE HARMONIZATION CONSORTIUM - ABSTRACT IN RESPONSE TO PAR-20-099 “HARMONIZATION OF ALZHEIMER’S DISEASE AND RELATED DEMENTIAS (AD/RD) GENETIC, EPIDEMIOLOGIC, AND CLINICAL DATA TO ENHANCE THERAPEUTIC TARGET…